SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006109
Filing Date
2024-02-29
Accepted
2024-02-29 16:30:17
Documents
18
Period of Report
2024-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240227_8k.htm   iXBRL 8-K 29652
2 EXHIBIT 10.1 ex_631955.htm EX-10.1 156498
3 EXHIBIT 10.2 ex_631956.htm EX-10.2 68208
4 EXHIBIT 10.3 ex_631957.htm EX-10.3 84339
  Complete submission text file 0001437749-24-006109.txt   536939

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240227.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240227_def.xml EX-101.DEF 11424
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240227_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240227_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240227_8k_htm.xml XML 2852
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 24704220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)